You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 12, December 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 39TH ANNUAL MEETING OF THE SOCIETY OF SURGICAL ONCOLOGY, WASHINGTON, DC, MAY 12 TO MAY 14, 1986-PART II
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Chemoprevention of Colorectal Neoplasms

Ascorbic Acid and β-Carotene

Thomas A. Colacchio, MD; Vincent A. Memoli, MD

Arch Surg. 1986;121(12):1421-1424.


Abstract

• The organospecific, 1,2-dimethylhydrazine—induced rat tumor model was used to test tumor formation in groups of animals receiving (1) regular chow, (2) powdered chow with 7%/wt ascorbic acid supplement, (3) pelleted chow with 1%/wt β-carotene supplement, and (4) pelleted chow with placebo beadlets. Following a 16-week induction period, animals were killed and tumor formation was recorded. Tumor formation in the ascorbic acid supplement group was found to be significantly less than the control group. The β-carotene group showed no difference in tumor formation compared with the placebo-beadlet control group. Tumor incidence was generally the same between the two control groups, and the ascorbic acid group had significantly fewer tumors than the β-carotene group. In sum, ascorbic acid supplements in high doses significantly decreased tumor formation, whereas β-carotene supplements in moderately high doses had no effect on tumor formation in this model.

(Arch Surg 1986;121:1421-1424)



Author Affiliations

From the Departments of Surgery (Dr Colacchio) and Pathology (Dr Memoli), Dartmouth-Hitchcock Medical Center, Hanover, NH.


Footnotes

Accepted for publication Aug 13, 1986.

Read before the 39th Annual Meeting of the Society of Surgical Oncology, Washington, DC, May 13, 1986.

Reprint requests to Dartmouth-Hitchcock Medical Center, 2 Maynard St, Hanover, NH 03756 (Dr Colacchio).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antioxidants vs Carotenoids: Inhibitors or Promoters of Experimental Colorectal Cancers
Colacchio et al.
Arch Surg 1989;124:217-221.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.